B of A Securities Initiates Coverage On AlloVir With Buy Rating, Announces Price Target of $17
B of A Securities Initiates Coverage On AlloVir With Buy Rating, Announces Price Target of $17
B of A Securities以買入評級開始對AlloVir進行保險，宣佈目標股價爲17美元
B of A Securities analyst Jason Zemansky initiates coverage on AlloVir (NASDAQ:ALVR) with a Buy rating and announces Price Target of $17.
Bof A Securities分析師傑森·澤曼斯基以買入評級開始對AlloVir（納斯達克股票代碼：ALVR）進行報道，並宣佈目標股價爲17美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。